DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

Johnson & Johnson (NYSE: JNJ)

102.37 0.41 (0.40%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JNJ $102.37 0.40%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $102.28
Previous Close $101.96
Daily Range $101.79 - $102.62
52-Week Range $81.79 - $108.99
Market Cap $283.3B
P/E Ratio 19.53
Dividend (Yield) $3.00 (2.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,353,779
Average Daily Volume 7,179,416
Current FY EPS $6.18




Drug Makers

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website:

News & Commentary

1 Dividend Stock to Rule Them All

Mirror, mirror, on the wall, what's the greatest dividend stock of them all?

Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for November 30, 2015

Low Expense, Low Fuss, Income Growth

SPY Vs. Dividend Growth Portfolio

How Johnson & Johnson Spent $71 Billion in 12 Months

A slideshow reveals three interesting points about the pharmaceutical giant.

Arrowhead Research: Some Questions For Management

The Schwab U.S. Dividend Equity ETF Is Better Than Social Security

Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen

Johnson & Johnson's newly approved multiple myeloma drug, Darzalex, is worth keeping an eye on for a number of reasons.

To Comfortably Beat The Market Dividend Growth Investors Should Consider CROIC

Gilead's (GILD) Cocktail HIV Drug Genvoya Approved in EU

See More JNJ News...

JNJ's Top Competitors

JNJ $102.37 (0.40%)
Current stock: JNJ
PFE $32.79 (-0.24%)
Current stock: PFE
MRK $53.96 (0.45%)
Current stock: MRK
BSX $18.33 (-0.27%)
Current stock: BSX